136k views
3 votes
U.S. health care reform legislation is a high-risk area for the pharmaceutical industry. This risk belongs to which risk category?

a. Internal risk, strategic
b. External risk, compliance
c. External risk, strategic
d. Internal risk, compliance

1 Answer

0 votes

Final answer:

The risk category that the high-risk area for the pharmaceutical industry belongs to is external risk, strategic.

Step-by-step explanation:

The risk category to which the high-risk area for the pharmaceutical industry belongs is external risk, strategic.

This category refers to risks that are beyond the control of a company and emerge from external factors, such as changes in government regulations and policies.

In the case of the pharmaceutical industry, the U.S. health care reform legislation poses a risk as it can significantly impact the industry's operations, pricing, and market access.

User OganM
by
7.8k points
Welcome to QAmmunity.org, where you can ask questions and receive answers from other members of our community.